The relationship between disability and depression in multiple sclerosis: The role of uncertainty, coping, and hope

Multiple Sclerosis

Volumn 7, Issue 6, 2001, Pages 411-416

  Lynch, S G ^a   Kroencke, D C ^a   Denney, D R ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Coping; Depression; Disability; Hope; Multiple sclerosis; Uncertainty

Indexed keywords

ANTIDEPRESSANT AGENT; BETA INTERFERON; GLATIRAMER; SPASMOLYTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CONSULTATION; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIPLE REGRESSION; MULTIPLE SCLEROSIS; PATIENT ATTITUDE; PHYSICIAN; PREDICTION; PSYCHOGENESIS; QUESTIONNAIRE; RATING SCALE; SELF EVALUATION; SELF REPORT; SOCIAL PROBLEM; SYMPTOM; VALIDATION PROCESS; VARIANCE;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; DEPRESSION; DISABILITY EVALUATION; DISABLED PERSONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROBABILITY;

EID: 0035210768     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801701566998     Document Type: Article

References (44)

1. Depression and multiple sclerosis
2. Mood disorder and dysfunction of the hypothalamic-pituitary-adrenal axis in multiples sclerosis
3. A prospective study of depression and immune dysregulation in multiple sclerosis
4. Depression, cognitive impairment of social stress in multiple sclerosis
5. Cognitive function in recent onset demyelinating disease
6. Correlates of cognitive impairment and depressed mood in multiple sclerosis
7. A new approach to affective symptoms in relapsing-remitting multiple sclerosis
8. Cerebrospinal fluid, somatostatin, mood, and cognition in multiple sclerosis
9. Psychiatric morbidity in multiple sclerosis: A clinical and MRI study
10. The measurement of fatigue in patients with multiple sclerosis
11. A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis
12. Adjustment to multiple sclerosis: Application of a stress and coping model
13. Brain MRI lesions and atrophy are related to depression in multiple sclerosis
14. Event-related auditory evoked potentials and multiple sclerosis
15. Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support
16. Depression, coping, and level of neurological impairment in multiple sclerosis
17. Assessment of depression in patients with primary motor neuron disease and other neurologically disabling illness
18. Depression as a major symptom of multiple sclerosis
19. Physical disability, life stress, and psychosocial adjustment in multiple sclerosis
20. Depression in multiple sclerosis
21. Depressive symptoms are not influenced by severity of multiple sclerosis
22. If it changes it must be a process: Study of emotion and coping during three stages of a college examination
23. Examination of the factor structure of the Ways of Coping Questionnaire with clinical populations
24. Stress and coping in multiple sclerosis: Exacerbation, remission, and chronic subgroups
25. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations
26. Coping with multiple sclerosis
27. Optimism and adaptation to multiple sclerosis: What does optimism mean?
28. A comparative analysis of coping behaviors in persons with multiple sclerosis or a spinal cord injury
29. Depression during exacerbations in multiple sclerosis: The importance of uncertainty
30. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
31. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
32. A self-rating depression scale
33. Identification of Beck Depression Inventory items related to multiple sclerosis
34. Mood disturbance versus other symptoms of depression in multiple sclerosis
35. The will and the ways: Development and validation of an individual-differences measure of hope
36. The measurement of uncertainty of illness
37. Coping with general and disease-related stressors by patients with multiple sclerosis: Relationships to psychological distress
38. MRI studies of multiple sclerosis: Implications for the natural history of the disease and for monitoring effectiveness of experimental procedures
39. Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis: The MS Study Group
40. MRI in multiple sclerosis: Correlation with expanded disability status scale (EDSS)
41. The role of magnetic resonance techniques in understanding and managing multiple sclerosis
42. Disease activity and emotional state in multiple sclerosis
43. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: An epidemiologic study
44. An investigation into some psychiatric aspects of multiple sclerosis